CID 11438726

N-(2-ethyl-2-methyl-4-oxo-thiazolidin-3-yl)-6-methyl-imidazo[2,1-b]thiazole-5-carboxamide

Structural Information

Molecular Formula
C13H16N4O2S2
SMILES
CCC1(N(C(=O)CS1)NC(=O)C2=C(N=C3N2C=CS3)C)C
InChI
InChI=1S/C13H16N4O2S2/c1-4-13(3)17(9(18)7-21-13)15-11(19)10-8(2)14-12-16(10)5-6-20-12/h5-6H,4,7H2,1-3H3,(H,15,19)
InChIKey
FDNHNXWKGHXSHZ-UHFFFAOYSA-N
Compound name
N-(2-ethyl-2-methyl-4-oxo-1,3-thiazolidin-3-yl)-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

324.07147 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 325.07875 170.9
[M+Na]+ 347.06069 183.0
[M-H]- 323.06419 176.7
[M+NH4]+ 342.10529 191.0
[M+K]+ 363.03463 179.5
[M+H-H2O]+ 307.06873 166.9
[M+HCOO]- 369.06967 183.5
[M+CH3COO]- 383.08532 183.1
[M+Na-2H]- 345.04614 168.1
[M]+ 324.07092 177.7
[M]- 324.07202 177.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.